Patents by Inventor Markus Mäegerlein

Markus Mäegerlein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Itraconazole compositions with improved bioavailability
    Patent number: 8486456
    Abstract: A solid dispersion product comprising itraconazole and hydroxypropyl methylcellulose, which satisfies the Formula 0.35>?Htr (1) (wherein ?Htr represents the endotherm (J/g) accompanying a transition at about 240° C). The solid dispersion product shows an improved bioavailability.
    Type: Grant
    Filed: August 8, 2006
    Date of Patent: July 16, 2013
    Assignee: Abbott GmbH & Co., KG
    Inventors: Gunther Berndl, Matthias Degenhardt, Markus Mäegerlein, Gerrit Dispersyn
  • Composition and Dosage Form Comprising a Solid or Semi-Solid Matrix
    Publication number: 20090220596
    Abstract: A composition which comprises a solid or semi-solid matrix having at least one active ingredient uniformly dispersed therein, the matrix comprising at least one pharmaceutically acceptable matrix-forming agent and a 1,3-bis(lactamyl)-butane compound, in particular 1,3-bis(pyrrolidon-1-yl)-butane. The active ingredient is preferably dispersed in the matrix in a state of a solid solution. The matrix-forming agent is preferably a pharmaceutically acceptable polymer. The composition is useful for the manufacture of pharmaceutical dosage forms.
    Type: Application
    Filed: June 22, 2006
    Publication date: September 3, 2009
    Applicant: Abbott GmbH & Co. KG
    Inventors: Jörg Rosenberg, Markus Mäegerlein, Jörg Breitenbach
  • ITRACONAZOLE COMPOSITIONS WITH IMPROVED BIOAVAILABILITY
    Publication number: 20090214656
    Abstract: A solid dispersion product comprising itraconazole and hydroxypropyl methylcellulose, which satisfies the Formula 0.35>?Htr (1) (wherein ?Htr represents the endotherm (J/g) accompanying a transition at about 240° C). The solid dispersion product shows an improved bioavailability.
    Type: Application
    Filed: August 8, 2006
    Publication date: August 27, 2009
    Applicants: ABBOTT GMBH & CO. KG, BARRIER THERAPEUTICS
    Inventors: Gunther Berndl, Matthias Degenhardt, Markus Mäegerlein, Gerrit Dispersyn